Actively Recruiting
Phase 1 Study of Oral Microgynon and Ganfeborole Interaction in Healthy Non-Childbearing Female Adults Aged 18 to 64 Years
Led by GlaxoSmithKline · Updated on 2026-10-02
28
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the pharmacokinetics, safety, and tolerability of Ganfeborole combined with Microgynon, an oral contraceptive containing ethinylestradiol EE and levonorgestrel LNG, in healthy female participants who are not capable of childbearing. This phase 1, open-label study aims to understand how these drugs behave when taken alone and together, focusing on potential interactions and effects in women aged 18 to 65 years. Participants will undergo two treatment periods. In the first period, they will take Microgynon daily from Day 1 to Day 10. The second period starts with a low dose of Ganfeborole on Day 11, followed by a high dose daily from Day 12 to Day 24 combined with Microgynon daily from Day 15 to Day 24. This fixed sequence allows study of the drugs both individually and in combination over approximately 24 days. During the study, participants will have blood samples taken at various timepoints to measure drug concentrations and hormone levels, including detailed pharmacokinetic assessments on Days 10 and 24. Safety is closely monitored through laboratory tests, electrocardiograms, vital signs, and adverse event tracking. The study also includes hormone binding protein level measurements. Overall participation lasts about 25 days, with frequent visits for dosing and monitoring to ensure participant safety and data collection.
CONDITIONS
Brief Title
A Study to Investigate the Repeat-dose Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With Ganfeborole in Female Participants of Non-childbearing Potential
Research Team
U
US GSK Clinical Trials Call Center
E
EU GSK Clinical Trials Call Center
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here